Mueller Medical, Turning Science into Solutions
Home About us Research and Development Products News Contact us
News

Walgreens Specialty Pharmacy Launches ProThelial™ Reducing the standard 84 day course of oral mucositis to 2-3 days or preventing it altogether, thereby averting surgical placement of feeding tubes 1, FDA cleared ProThelial™ is the focal point the new partnership between Mueller Medical International (MMI) and Walgreens Specialty Pharmacy. [Read more] MASCC/ISOO 2015 International Symposium Representatives from Mueller Medical International will attend the MASCC/ISOO 2015 International Symposium in Miami, Florida from June 26 – 28 to raise awareness of ProThelial™ among medical professionals. ProThelial™ is an FDA-cleared medical device that not only eliminates the symptoms of oral mucositis, but reverses them, cutting short the course to a few days, keeping patients mucositis-free while continuing treatment at a fraction of the cost of traditional treatments. [Read more] Oral, Head and Neck Cancer Awareness Month The month of April was Oral, Head and Neck Cancer Awareness Month. According to the Oral Cancer Foundation, 43,250 people in the U.S. will be diagnosed with oral cancer this year. One unfortunate and debilitating side effect for people undergoing chemotherapy for oral cancer is mucositis, a condition that causes painful lesions and ulcers, most often in the oral cavity, pharynx and the esophagus, though it may affect the small and large intestines, causing pain, nausea, vomiting, cramping and diarrhea. [Read more]